![Zach Scheiner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Zach Scheiner
Direktor/Vorstandsmitglied bei
NKARTA, INC.
Vermögen: - $ am 30.06.2026
Profil
Zachary Scheiner currently serves as Independent Director at SpyGlass Pharma, Inc. since 2023; Director at Adagio Medical, Inc., LENZ Therapeutics Operations, Inc., and Nkarta, Inc. since 2020; Director at Exo Imaging, Inc. since 2021; Director at Sydnexis, Inc. since 2017; Principal at RA Capital Management LP (Private Equity) since 2017; and Principal at RA Capital Management LP since 2015.
Former roles include Independent Director at LENZ Therapeutics, Inc. from 2024 to 2026 and Chief Science Officer at California Institute for Regenerative Medicine from 2008 to 2015.
Education includes a doctorate from the University of Washington conferred in 2007 and an undergraduate degree from Yale University conferred in 1997.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
-.--% | 15.06.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
NKARTA, INC. -.--% | 10.06.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
| 05.02.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
Aktive Positionen von Zach Scheiner
| Unternehmen | Position | Beginn |
|---|---|---|
| NKARTA, INC. | Direktor/Vorstandsmitglied | 01.02.2020 |
| SPYGLASS PHARMA, INC. | Direktor/Vorstandsmitglied | 01.07.2023 |
RA Capital Management LP
 RA Capital Management LP Investment ManagersFinance RA Capital is a multi-stage investment manager that focuses evidence-based investing in public and private healthcare and life science companies which develops drugs, medical devices, diagnostics, services, and research tools. The firm’s portfolio of private and public companies spans the globe and most therapeutic areas across all stages from discovery through commercialization. | Analyst-Equity | 01.04.2015 |
RA Capital Management LP (Private Equity)
 RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement. | Private Equity Investor | 01.12.2017 |
Adagio Medical, Inc.
 Adagio Medical, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company which focuses in cardiology | Direktor/Vorstandsmitglied | 01.11.2020 |
Exo Imaging, Inc.
 Exo Imaging, Inc. Medical SpecialtiesHealth Technology Develops handheld ultrasound devices and AI for imaging & therapeutic applications | Direktor/Vorstandsmitglied | 01.06.2021 |
Sydnexis, Inc.
 Sydnexis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direktor/Vorstandsmitglied | 01.10.2017 |
LENZ Therapeutics, Inc.
 LENZ Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops aceclidine-based eye drops | Direktor/Vorstandsmitglied | 01.11.2020 |
Ehemalige bekannte Positionen von Zach Scheiner
| Unternehmen | Position | Ende |
|---|---|---|
California Institute for Regenerative Medicine
 California Institute for Regenerative Medicine General GovernmentGovernment Provides medical services | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2015 |
Ausbildung von Zach Scheiner
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
95
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
RA Capital Management LP
RA Capital Management LP Investment ManagersFinance RA Capital is a multi-stage investment manager that focuses evidence-based investing in public and private healthcare and life science companies which develops drugs, medical devices, diagnostics, services, and research tools. The firm’s portfolio of private and public companies spans the globe and most therapeutic areas across all stages from discovery through commercialization. | Finance |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Institute for Regenerative Medicine
California Institute for Regenerative Medicine General GovernmentGovernment Provides medical services | Government |
Adagio Medical, Inc.
Adagio Medical, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company which focuses in cardiology | Health Technology |
Exo Imaging, Inc.
Exo Imaging, Inc. Medical SpecialtiesHealth Technology Develops handheld ultrasound devices and AI for imaging & therapeutic applications | Health Technology |
Sydnexis, Inc.
Sydnexis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Nkarta, Inc.
 Nkarta, Inc. BiotechnologyHealth Technology Discovers, develops and delivers NK cell therapies for cancer treatment | Health Technology |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement. | Finance |
LENZ Therapeutics, Inc.
LENZ Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops aceclidine-based eye drops | Health Technology |
SpyGlass Pharma Inc
 SpyGlass Pharma Inc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops IOL-mounted drug delivery platform for glaucoma patients | Health Technology |
